Role of zinc homeostasis in the pathogenesis of diabetes and obesity

A Fukunaka, Y Fujitani - International journal of molecular sciences, 2018 - mdpi.com
Zinc deficiency is a risk factor for obesity and diabetes. However, until recently, the
underlying molecular mechanisms remained unclear. The breakthrough discovery that the …

Proteolytic degradation of amyloid β-protein

T Saido, MA Leissring - Cold Spring …, 2012 - perspectivesinmedicine.cshlp.org
The amyloid β-protein (Aβ) is subject to proteolytic degradation by a diverse array of
peptidases and proteinases, known collectively as Aβ-degrading proteases (AβDPs). A …

Anti-diabetic activity of insulin-degrading enzyme inhibitors mediated by multiple hormones

JP Maianti, A McFedries, ZH Foda, RE Kleiner, XQ Du… - Nature, 2014 - nature.com
Despite decades of speculation that inhibiting endogenous insulin degradation might treat
type-2 diabetes,, and the identification of IDE (insulin-degrading enzyme) as a diabetes …

The diabetes-susceptible gene SLC30A8/ZnT8 regulates hepatic insulin clearance

M Tamaki, Y Fujitani, A Hara, T Uchida… - The Journal of …, 2013 - Am Soc Clin Investig
Recent genome-wide association studies demonstrated that common variants of solute
carrier family 30 member 8 gene (SLC30A8) increase susceptibility to type 2 diabetes …

Insulin‐degrading enzyme: an ally against metabolic and neurodegenerative diseases

L Sousa, M Guarda, MJ Meneses… - The Journal of …, 2021 - Wiley Online Library
Insulin‐degrading enzyme (IDE) function goes far beyond its known proteolytic role as a
regulator of insulin levels. IDE has a wide substrate promiscuity, degrading several proteins …

Are amyloid‐degrading enzymes viable therapeutic targets in Alzheimer's disease?

NN Nalivaeva, C Beckett, ND Belyaev… - Journal of …, 2012 - Wiley Online Library
J. Neurochem.(2012) 120 (Suppl. 1), 167–185. Abstract The amyloid cascade hypothesis of
Alzheimer's disease envisages that the initial elevation of amyloid β‐peptide (Aβ) levels …

Insulin-degrading enzyme: new therapeutic target for diabetes and Alzheimer's disease?

O Pivovarova, A Höhn, T Grune, AFH Pfeiffer… - Annals of …, 2016 - Taylor & Francis
Insulin-degrading enzyme (IDE) is a major enzyme responsible for insulin degradation. In
addition to insulin, IDE degrades many targets including glucagon, atrial natriuretic peptide …

Modulation of insulin sensitivity by insulin-degrading enzyme

CM González-Casimiro, B Merino… - Biomedicines, 2021 - mdpi.com
Insulin-degrading enzyme (IDE) is a highly conserved and ubiquitously expressed
metalloprotease that degrades insulin and several other intermediate-size peptides. For …

Brain signaling systems in the type 2 diabetes and metabolic syndrome: promising target to treat and prevent these diseases

AO Shpakov, KV Derkach, LM Berstein - Future science OA, 2015 - Taylor & Francis
The changes in the brain signaling systems play an important role in etiology and
pathogenesis of Type 2 diabetes mellitus (T2DM) and metabolic syndrome (MS), being a …

Highly efficient synthesis of isoxazolones and pyrazolones using gC3N4·OH nanocomposite with their in silico molecular docking, pharmacokinetics and simulation …

S Soni, S Teli, P Teli, A Manhas, PC Jha, S Agarwal - Scientific Reports, 2024 - nature.com
An environmentally friendly, versatile multicomponent reaction for synthesizing isoxazol-5-
one and pyrazol-3-one derivatives has been developed, utilizing a freshly prepared g-C3N4 …